BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9052848)

  • 1. Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats.
    Rodriguez-Barbero A; López-Novoa JM; Arévalo M
    Exp Nephrol; 1997; 5(1):47-54. PubMed ID: 9052848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the platelet activating factor antagonist BN52021 in rabbits: role in gentamicin nephrotoxicity.
    Hanslik T; Blanchet F; Nochy D; Pirotzky E; Guilmard C; Seta N; Carbon C
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):111-5. PubMed ID: 8079343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
    López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
    J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of platelet activating factor antagonist treatment on gentamicin nephrotoxicity.
    Rodriguez-Barbero A; Bosque E; Rivas-Cabaero L; Arévalo M; López-Novoa JM
    Mediators Inflamm; 1992; 1(1):23-6. PubMed ID: 18475436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of platelet-activating factor-induced acute renal failure by BN 52021.
    Pirotzky E; Colliez P; Guilmard C; Schaeverbeke J; Mencia-Huerta JM; Braquet P
    Br J Exp Pathol; 1988 Apr; 69(2):291-9. PubMed ID: 3377967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
    Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity.
    Dos Santos OF; Boim MA; Barros EJ; Schor N
    Kidney Int; 1991 Oct; 40(4):742-7. PubMed ID: 1745025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin nephrotoxicity in the rat: influence of age and diabetes mellitus.
    Ali BH; Bashir AK; Mugamer IT; Tanira MO
    Hum Exp Toxicol; 1996 Jan; 15(1):51-55. PubMed ID: 8845210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor antagonist, BN-52021 protects against cis-diamminedichloroplatinum nephrotoxicity in the rat.
    Pirotzky E; Guilmard C; Sidoti C; Ivanow F; Principe P; Braquet P
    Ren Fail; 1990; 12(3):171-6. PubMed ID: 2287769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin activates rat mesangial cells. A role for platelet activating factor.
    Rodriguez-Barbero A; Rodriguez-Lopez AM; Gonzalez-Sarmiento R; López-Novoa JM
    Kidney Int; 1995 May; 47(5):1346-53. PubMed ID: 7637264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of trans-resveratrol on gentamicin-induced nephrotoxicity.
    Morales AI; Buitrago JM; Santiago JM; Fernández-Tagarro M; López-Novoa JM; Pérez-Barriocanal F
    Antioxid Redox Signal; 2002 Dec; 4(6):893-8. PubMed ID: 12573138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist.
    Bagnis C; Deray G; Dubois M; Pirotzky E; Jacquiaud C; Baghos W; Aupetit B; Braquet P; Jacobs C
    Nephrol Dial Transplant; 1996 Mar; 11(3):507-13. PubMed ID: 8671822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
    Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J
    Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of platelet-activating factor antagonist on cyclosporine nephrotoxicity. Glomerular hemodynamics evaluation.
    dos Santos OF; Boim MA; Bregman R; Draibe SA; Barros EJ; Pirotzky E; Schor N; Braquet P
    Transplantation; 1989 Apr; 47(4):592-5. PubMed ID: 2705209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of co-supplementation of vitamins E and C on gentamicin-induced nephrotoxicity in rat.
    Kadkhodaee M; Khastar H; Faghihi M; Ghaznavi R; Zahmatkesh M
    Exp Physiol; 2005 Jul; 90(4):571-6. PubMed ID: 15769882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gentamicin on isolated glomeruli and proximal tubules of the rabbit.
    Savin V; Karniski L; Cuppage F; Hodges G; Chonko A
    Lab Invest; 1985 Jan; 52(1):93-102. PubMed ID: 3965802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of L-arginine on gentamicin-induced nephrotoxicity in rats.
    Başhan İ; Başhan P; Seçilmiş MA; Şingirik E
    Indian J Pharmacol; 2014; 46(6):608-12. PubMed ID: 25538331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased renal glomerular endothelin-1 release in gentamicin-induced nephrotoxicity.
    Valdivielso JM; Rivas-Cabañero L; Morales AI; Arévalo M; López-Novoa JM; Pérez-Barriocanal F
    Int J Exp Pathol; 1999 Oct; 80(5):265-70. PubMed ID: 10607017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor mediates glycerol-induced acute renal failure in rats.
    López-Farré A; Gómez-Garre D; Bernabeu F; Ramón y Cajal S; Perez-Rodrigo P; Braquet P; López-Novoa JM
    Clin Sci (Lond); 1990 Dec; 79(6):551-8. PubMed ID: 2176942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin attenuates gentamicin-induced renal oxidative damage in rats.
    Farombi EO; Ekor M
    Food Chem Toxicol; 2006 Sep; 44(9):1443-8. PubMed ID: 16814915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.